HLS Therapeutics Inc.
HLTRF
$2.96
-$0.33-10.03%
OTC PK
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 17.46M | 17.54M | 32.52M | 19.44M | 21.95M |
| Total Receivables | 7.53M | 10.59M | 9.21M | 9.65M | 10.69M |
| Inventory | 9.06M | 7.68M | 8.80M | 10.09M | 9.53M |
| Prepaid Expenses | 1.36M | -- | -- | -- | 1.91M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | 1.77M | 2.34M | 1.60M | 2.00K |
| Total Current Assets | 35.40M | 37.57M | 52.86M | 40.78M | 44.10M |
|
|
|||||
| Total Current Assets | 35.40M | 37.57M | 52.86M | 40.78M | 44.10M |
| Net Property, Plant & Equipment | 997.00K | 897.00K | 701.00K | 824.00K | 965.00K |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | 122.12M | 132.04M | 136.39M | 154.46M | 162.34M |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 1.39M | 1.23M | 1.38M | 1.69M | 1.66M |
| Total Assets | 159.90M | 171.74M | 191.32M | 197.75M | 209.06M |
|
|
|||||
| Total Accounts Payable | 8.71M | 13.48M | 12.32M | 13.13M | 14.11M |
| Total Accrued Expenses | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 5.28M | 4.81M | 5.10M | 5.13M | 5.16M |
| Total Finance Division Other Current Liabilities | 8.55M | 5.80M | 8.70M | 7.94M | 7.43M |
| Total Other Current Liabilities | 8.55M | 5.80M | 8.70M | 7.94M | 7.43M |
| Total Current Liabilities | 22.55M | 24.09M | 26.12M | 26.19M | 26.69M |
|
|
|||||
| Total Current Liabilities | 22.55M | 24.09M | 26.12M | 26.19M | 26.69M |
| Long-Term Debt | 60.74M | 63.43M | 77.75M | 79.67M | 82.05M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 426.00K | 376.00K | 222.00K | 301.00K | 420.00K |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 4.85M | 4.51M | 4.53M | 2.52M | 2.21M |
| Total Liabilities | 88.56M | 92.41M | 108.62M | 108.69M | 111.36M |
|
|
|||||
| Common Stock & APIC | 275.73M | 275.50M | 275.19M | 275.36M | 275.99M |
| Retained Earnings | -194.18M | -191.16M | -186.31M | -181.08M | -175.46M |
| Treasury Stock & Other | -10.21M | -5.02M | -6.17M | -5.21M | -2.84M |
| Total Common Equity | 71.34M | 79.33M | 82.71M | 89.07M | 97.70M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 71.34M | 79.33M | 82.71M | 89.07M | 97.70M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 71.34M | 79.33M | 82.71M | 89.07M | 97.70M |
|
|
|||||